Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.Rheumatology (Oxford, England)|January 13, 2023
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)Deborah J Griffiths-Jones, Yvonne Sylvestre Garcia, W David Ryder, et al.Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.Rheumatology (Oxford, England)|September 22, 2014
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?Dennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.RMD Open|August 6, 2016
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokinesNadia Howard Tripp, Jessica Tarn, Andini Natasari, et al.Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.RMD Open|June 7, 2019
Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndromeKate L Hackett, Kristen Davies, Jessica Tarn, et al.Arthritis Care & Research|December 20, 2016
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the DiscrepancyOriana M Bezzina, Peter Gallagher, Sheryl Mitchell, et al.Pageof 6